These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24927416)

  • 1. Incretin receptor null mice reveal key role of GLP-1 but not GIP in pancreatic beta cell adaptation to pregnancy.
    Moffett RC; Vasu S; Thorens B; Drucker DJ; Flatt PR
    PLoS One; 2014; 9(6):e96863. PubMed ID: 24927416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional GIP receptors play a major role in islet compensatory response to high fat feeding in mice.
    Moffett RC; Vasu S; Flatt PR
    Biochim Biophys Acta; 2015 Jun; 1850(6):1206-14. PubMed ID: 25688757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endogenous GLP-1 and GIP in beta cell compensatory responses to insulin resistance and cellular stress.
    Vasu S; Moffett RC; Thorens B; Flatt PR
    PLoS One; 2014; 9(6):e101005. PubMed ID: 24967820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function.
    Shu L; Matveyenko AV; Kerr-Conte J; Cho JH; McIntosh CH; Maedler K
    Hum Mol Genet; 2009 Jul; 18(13):2388-99. PubMed ID: 19386626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice.
    Maida A; Hansotia T; Longuet C; Seino Y; Drucker DJ
    Gastroenterology; 2009 Dec; 137(6):2146-57. PubMed ID: 19766644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion.
    Fujita Y; Wideman RD; Asadi A; Yang GK; Baker R; Webber T; Zhang T; Wang R; Ao Z; Warnock GL; Kwok YN; Kieffer TJ
    Gastroenterology; 2010 May; 138(5):1966-75. PubMed ID: 20138041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells.
    Moens K; Heimberg H; Flamez D; Huypens P; Quartier E; Ling Z; Pipeleers D; Gremlich S; Thorens B; Schuit F
    Diabetes; 1996 Feb; 45(2):257-61. PubMed ID: 8549871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice.
    Pederson RA; Satkunarajah M; McIntosh CH; Scrocchi LA; Flamez D; Schuit F; Drucker DJ; Wheeler MB
    Diabetes; 1998 Jul; 47(7):1046-52. PubMed ID: 9648827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.
    Hansotia T; Drucker DJ
    Regul Pept; 2005 Jun; 128(2):125-34. PubMed ID: 15780432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.
    Pamir N; Lynn FC; Buchan AM; Ehses J; Hinke SA; Pospisilik JA; Miyawaki K; Yamada Y; Seino Y; McIntosh CH; Pederson RA
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E931-9. PubMed ID: 12540373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors.
    Preitner F; Ibberson M; Franklin I; Binnert C; Pende M; Gjinovci A; Hansotia T; Drucker DJ; Wollheim C; Burcelin R; Thorens B
    J Clin Invest; 2004 Feb; 113(4):635-45. PubMed ID: 14966573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of human incretin receptor missense variants.
    Fortin JP; Schroeder JC; Zhu Y; Beinborn M; Kopin AS
    J Pharmacol Exp Ther; 2010 Jan; 332(1):274-80. PubMed ID: 19841474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the insulinotropic and glucose-lowering actions of zebrafish GIP in mammalian systems: Evidence for involvement of the GLP-1 receptor.
    Graham GV; Conlon JM; Abdel-Wahab YH; Gault VA; Flatt PR
    Peptides; 2018 Feb; 100():182-189. PubMed ID: 29157578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice.
    Parker JC; Lavery KS; Irwin N; Green BD; Greer B; Harriott P; O'Harte FP; Gault VA; Flatt PR
    J Endocrinol; 2006 Oct; 191(1):93-100. PubMed ID: 17065392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPR119 regulates murine glucose homeostasis through incretin receptor-dependent and independent mechanisms.
    Flock G; Holland D; Seino Y; Drucker DJ
    Endocrinology; 2011 Feb; 152(2):374-83. PubMed ID: 21068156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic exposure to incretin metabolites GLP-1(9-36) and GIP(3-42) affect islet morphology and beta cell health in high fat fed mice.
    Sridhar A; Khan D; Babu G; Irwin N; Gault VA; Flatt PR; Moffett CR
    Peptides; 2024 Aug; 178():171254. PubMed ID: 38815655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLP-1 receptor agonism and GIP receptor antagonism induce substantial alterations in enteroendocrine and islet cell populations in obese high fat fed mice.
    Sridhar A; Khan D; Flatt PR; Moffett CR; Irwin N
    Peptides; 2023 Nov; 169():171093. PubMed ID: 37660881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon and insulin secretion, insulin clearance, and fasting glucose in GIP receptor and GLP-1 receptor knockout mice.
    Tura A; Pacini G; Yamada Y; Seino Y; Ahrén B
    Am J Physiol Regul Integr Comp Physiol; 2019 Jan; 316(1):R27-R37. PubMed ID: 30462524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
    Flamez D; Van Breusegem A; Scrocchi LA; Quartier E; Pipeleers D; Drucker DJ; Schuit F
    Diabetes; 1998 Apr; 47(4):646-52. PubMed ID: 9568699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Umami receptor activation increases duodenal bicarbonate secretion via glucagon-like peptide-2 release in rats.
    Wang JH; Inoue T; Higashiyama M; Guth PH; Engel E; Kaunitz JD; Akiba Y
    J Pharmacol Exp Ther; 2011 Nov; 339(2):464-73. PubMed ID: 21846840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.